Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea · Delayed Price · Currency is KRW 6,800.00
+350.00 (5.43%)
At close: Apr 3, 2026
Finemedix Revenue
In the year 2025, Finemedix had annual revenue of 9.52B KRW, down -4.39%. Finemedix had revenue of 2.97B in the quarter ending December 31, 2025, a decrease of -24.46%.
Revenue
9.52B
Revenue Growth
-4.39%
P/S Ratio
3.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
36.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.52B | -437.66M | -4.39% |
| Dec 31, 2024 | 9.96B | -193.73M | -1.91% |
| Dec 31, 2023 | 10.15B | 2.01B | 24.71% |
| Dec 31, 2022 | 8.14B | 888.41M | 12.25% |
| Dec 31, 2021 | 7.25B | -656.61M | -8.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 114.25B |
| Synergy Innovation | 113.05B |
| Corentec | 100.43B |
| M.I.TECH Co.,Ltd | 67.15B |
| BIOBIJOU | 28.49B |
| Alpha AI | 25.98B |
| Bio Protech | 20.58B |
| Sanigen Co. | 15.35B |